REGIS HEALTHCARE LIMITED (REG)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

REG

REG - REGIS HEALTHCARE LIMITED

FNArena Sector : Aged Care & Seniors
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 0.05
Index: ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$6.72

25 Jun
2026

0.110

OPEN

$6.66

1.66%

HIGH

$6.79

267,253

LOW

$6.59

TARGET
$8.60

+0.05 change from previous day

28.0% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
EGH . INA . LIC . OCA . RYM . SNZ .
FNARENA'S MARKET CONSENSUS FORECASTS
REG: 1
Title FY25
Actual
FY26
Actual
FY27
Forecast
FY28
Forecast
EPS (cps) xxx 18.4 18.5 xxx
DPS (cps) xxx 18.4 19.2 xxx
EPS Growth xxx 13.5% 0.3% xxx
DPS Growth xxx 13.4% 4.3% xxx
PE Ratio xxx N/A 25.9 xxx
Dividend Yield xxx N/A 4.0% xxx
Div Pay Ratio(%) xxx 99.8% 103.8% xxx

Dividend yield today if purchased 3 years ago: 7.36%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

3.83

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

$ 

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 08/09 - ex-div 9.40c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx18.4
DPS All xxxxxxxxxxxxxxx18.4
Sales/Revenue xxxxxxxxxxxxxxx1,343.6 M
Book Value Per Share xxxxxxxxxxxxxxx-4.0
Net Operating Cash Flow xxxxxxxxxxxxxxx336.3 M
Net Profit Margin xxxxxxxxxxxxxxx4.14 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx-
Return on Invested Capital xxxxxxxxxxxxxxx-
Return on Assets xxxxxxxxxxxxxxx2.37 %
Return on Equity xxxxxxxxxxxxxxx-
Return on Total Capital xxxxxxxxxxxxxxx-
Free Cash Flow ex dividends xxxxxxxxxxxxxxx142.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx3 M
Total Debt xxxxxxxxxxxxxxx4 M
Goodwill - Gross xxxxxxxxxxxxxxx695 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx174 M
Price To Book Value xxxxxxxxxxxxxxx-

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx142.0 M
Capex % of Sales xxxxxxxxxxxxxxx10.57 %
Cost of Goods Sold xxxxxxxxxxxxxxx1,191 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx102 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx127 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Ord Minnett

30/04/2026

1

Buy

$8.60

27.98%

Ord Minnett notes the Commonwealth has released its independent review of residential aged care accommodation pricing and announced a $3bn funding package to be included in the May budget.

The broker finds the most material recommendations include an updated accommodation supplement framework and deregulation of the DAP (daily accommodation payment) rate.

Accommodation funding is becoming the primary driver of returns in the medium term, the broker adds, driven by RAD (refundable accommodation deposit) retention and higher DAP income.

Buy rating retained. Target rises to $8.60 from $8.40.

FORECAST
Ord Minnett forecasts a full year FY26 dividend of 17.30 cents and EPS of 18.10 cents.
Ord Minnett forecasts a full year FY27 dividend of 24.30 cents and EPS of 24.20 cents.

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

22/06/2026

3

Downgrade to Neutral from Overweight

$7.50

11.61%

Jarden downgrades Regis Healthcare to Neutral from Overweight with its target price decreased to $7.50 following a regulatory review of recent sector legislative shifts.

Industry channel checks reveal that initial adoption rates for the Higher Everyday Living Fee voluntary package remain less robust than previously modeled, as macro cost-of-living pressures prompt incoming residents to opt out.

The analyst notes this operational headwind is further compounded by a delayed implementation timeline for federal accommodation supplement increases, which are deferred to March 2027 due to government software bottlenecks.

Revisions drive a -11.3% reduction to FY27 diluted EPS forecasts and a -14.3% drop for FY28 to encapsulate the slowed funding transitions.

Commentary concludes long-term corporate value remains supported by severe macro bed supply deficits, which will eventually catalyse structural accommodation pricing power once immediate legislative head-winds clear.

FORECAST
Jarden forecasts a full year FY26 dividend of 18.00 cents and EPS of 18.40 cents.
Jarden forecasts a full year FY27 dividend of 20.60 cents and EPS of 23.50 cents.

REG STOCK CHART